KATHE LUNDGREN: Open Payments
NPI 1457381816 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 95 payments from 8 companies in 2025. Trend: 2023 $922 · 2024 $711 · 2025 $1,740
Food & beverage: $1,545Education: $195
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 35 | $600 |
| E.R. Squibb & Sons, L.L.C. | 13 | $264 |
| Otsuka America Pharmaceutical, Inc. | 15 | $236 |
| Vanda Pharmaceuticals Inc. | 10 | $193 |
| Alkermes, Inc. | 8 | $148 |
| Lundbeck LLC | 7 | $138 |
| Noven Therapeutics, LLC | 6 | $128 |
| Axsome Therapeutics, Inc. | 1 | $33 |
Products named: AUSTEDO XR, REXULTI, COBENFY, HETLIOZ, ARISTADA, Secuado, ABILIFY ASIMTUFII, Auvelity.
Industry payments across CA — which companies pay providers there.
